Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stocks take a breather as Brexit, U.S. stimulus talks stall

Published 12/09/2020, 06:47 PM
Updated 12/10/2020, 01:25 AM
© Reuters. A man wearing a protective face mask walks past a stock quotation board outside a brokerage, amid the coronavirus disease (COVID-19) outbreak, in Tokyo

By Tom Westbrook

SINGAPORE (Reuters) - Asian equities eased from record highs on Thursday as stalled U.S. stimulus talks and a sell-off in tech stocks weighed, while sterling traders sat on a knife's edge as last-ditch Brexit negotiations yielded only an agreement to keep talking.

MSCI's broadest index of Asia-Pacific shares outside Japan eased 0.34%. Japan's Nikkei erased early losses to trade 0.1% lower. Both are up more than 60% from March lows. S&P 500 futures meanwhile pared early gains and steadied in Asian afternoon trade.

U.S. Treasuries rose while the dollar slightly eased after a volatile overnight session in currency markets, with traders now looking ahead to a European Central Bank monetary policy meeting. Sterling teetered at $1.3366 as it awaits a Brexit resolution.

"We've risen so far so fast that it's making investors cautious," said Michael McCarthy, chief strategist at stockbroker CMC Markets in Sydney.

"The fall in tech stocks was a bit of a concern, given that they've risen in all market weather over the last six weeks, so to see them come off might signal that we're looking at a short term corrective move."

A near 2% drop in the Nasdaq on Wednesday was driven by a 1.9% fall in Facebook (NASDAQ:FB) shares after U.S. regulators filed lawsuits alleging the company used its dominance to buy or crush rivals, harming competition.

Meanwhile, S&P Dow Jones Indices said on Thursday it would remove ten Chinese companies from its equities indices and several others from its bond indices.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This move comes after a Trump administration order to prohibit purchases by U.S. investors of certain Chinese securities. Index provider FTSE Russell did the same last week.

TRICKY TALKS

Cautious trading in Asia came amid widespread uncertainty surrounding long-running U.S. pandemic relief negotiations and talks between Britain and the European Union over trade arrangements post Brexit.

U.S. lawmakers approved a stopgap government funding bill on Wednesday, but were unable to sort out disagreements over aid to state and local governments that are holding up a broader spending package.

British and EU leaders meanwhile gave themselves until the end of the weekend to seal a new trade pact, with some $1 trillion in annual trade at risk of tariffs if they can't reach a deal by Dec. 31, when transition arrangements end.

British and European futures slipped marginally in Asia, with FTSE futures little changed and EuroSTOXX 50 futures down 0.14%.

Investor focus will shift towards a European Central Bank meeting later on Thursday, where the central bank is expected to unveil more bond buying and cheap loans.

Traders are also looking to see whether the ECB will say anything about a near 14% rise in the common currency from March lows, which is hindering Europe's exporters.

"We do not think there will be an explicit talking down of the euro, but expect ECB Chief (Christine) Lagarde to mention the central bank is keenly monitoring the currency strength," analysts at Singapore's OCBC Bank said in a note.

Elsewhere, faith in the recovery appears to be holding up, with oil prices steady despite a build-up in U.S. inventories. Brent crude futures last sat 0.27% firmer at $49.13 a barrel and U.S. crude was up 0.29% at $45.81 a barrel.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Gold nursed losses at $1,839 an ounce.

Treasuries traded firmly owing to uncertainty around U.S. stimulus wrangling, and the yield on benchmark U.S. ten-year bonds fell 1.2 basis points to 0.9278%.

"The uncertainty around the timing is less important than the uncertainty around the overall size of the package, which depends primarily on the outcome of the Senate runoffs in Georgia on January 5," Goldman Sachs (NYSE:GS) analysts said in a note.

"For now, our assumption is a $700 billion COVID relief package," they said, adding it would be upgraded to between $1 trillion and $1.5 trillion if Democrats win the two seats.

Latest comments

Headline should have read: Stocks Slip Off Highs, S-P Index P/E Still At Record, Over 37/1.
money, rich take it all...ask ,em pay medicine...not enough for yemen childs...Sir Paul of ruth less Beatless—grace fules..ask him give...he stole yesterday...jude...let it be..plus..ask give back..he pretend can not ask humanity for musical child...ev il to be so lazy..arro gant...
Nobody cares about Jerry Chan....another uneducated Trumper.
Jerry is right. This brexit deal lasted for 5 years. 5 years ago every day "experts" assured that without a prompt deal the world economy would be ruined.
Last time I saw the market like this was February and August...
Below censorship bleep = k/i/l/l.
NEW POLL by NewsMax. Now I’ve seen everything. Donny Trump has spent billions of dollars of taxpayer money and twisted every conventional wisdom regarding vaccine approval with his Warp Speed initiative, and now only 7% of Trumpers will take the vaccine because they think it will ******them. They believe that Trump has intentionally seen to it that the vaccine will be lethal for them ONLY, and no Biden voters, because they failed to re-elect him by not voting by mail more than once. Newsmax has said that far right-wing scientists and doctors have confirmed this is true, and that everyone who voted for Trump only one time in 2020 should be forewarned.
nobody cares about Brexit
You should! There eventually will be good news about a US / UK trade agreement that Joe Biden will nail down. A big boost for US markets!
Funny. There was no mention here in the United States about adverse reactions to the Pfizer Vaccine.
there was.something on cnbc late in the day. not a major deal.
Correction time!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.